Cargando…
Layered Double Hydroxide-Loaded miR-30a for the Treatment of Breast Cancer In Vitro and In Vivo
[Image: see text] MicroRNAs (miRNAs) play an essential role in cancer therapy, but the disadvantages of its poor inherent stability, rapid clearance, and low delivery efficiency affect the therapeutic efficiency. Loading miRNAs by nanoformulations can improve their bioavailability and enhance therap...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233669/ https://www.ncbi.nlm.nih.gov/pubmed/37273596 http://dx.doi.org/10.1021/acsomega.2c07866 |
_version_ | 1785052305793482752 |
---|---|
author | Zhang, Shiwen Pang, Siyan Pei, Wenhao Zhu, Haitao Shi, Yingxiang Liu, Ziyang Mao, Lingyu Shi, Xiuru Tao, Shuang Geng, Chenchen Chen, Sulian Yang, Linnan Chen, Changjie Yang, Qingling Wang, Wenrui |
author_facet | Zhang, Shiwen Pang, Siyan Pei, Wenhao Zhu, Haitao Shi, Yingxiang Liu, Ziyang Mao, Lingyu Shi, Xiuru Tao, Shuang Geng, Chenchen Chen, Sulian Yang, Linnan Chen, Changjie Yang, Qingling Wang, Wenrui |
author_sort | Zhang, Shiwen |
collection | PubMed |
description | [Image: see text] MicroRNAs (miRNAs) play an essential role in cancer therapy, but the disadvantages of its poor inherent stability, rapid clearance, and low delivery efficiency affect the therapeutic efficiency. Loading miRNAs by nanoformulations can improve their bioavailability and enhance therapeutic efficiency, which is an effective miRNA delivery strategy. In this study, we synthesized layered double hydroxides (LDH), which are widely used as carriers of drugs or genes due to the characteristics of good biocompatibility, high loading capacity, and pH sensitivity. We loaded the suppressor oncogene miR-30a on LDH nanomaterials (LDH@miR-30a) and determined the mass ratio of miRNA binding to LDH by agarose gel electrophoresis. LDH@miR-30a was able to escape the lysosomal pathway and was successfully phagocytosed by breast cancer SKBR3 cells and remained detectable in the cells after 24 h of co-incubation. In vitro experiments showed that LDH@miR-30a-treated SKBR3 cells showed decreased proliferation and cell cycle arrest in the G0/G1 phase and LDH@miR-30a was able to regulate the epithelial–mesenchymal transition (EMT) process and inhibit cell migration and invasion by targeting SNAI1. Meanwhile, in vivo experiments showed that nude mice treated with LDH@miR-30a showed a significant reduction in their solid tumors and no significant impairment of vital organs was observed. In conclusion, LDH@miR-30a is an effective drug delivery system for the treatment of breast cancer. |
format | Online Article Text |
id | pubmed-10233669 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | American Chemical Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-102336692023-06-02 Layered Double Hydroxide-Loaded miR-30a for the Treatment of Breast Cancer In Vitro and In Vivo Zhang, Shiwen Pang, Siyan Pei, Wenhao Zhu, Haitao Shi, Yingxiang Liu, Ziyang Mao, Lingyu Shi, Xiuru Tao, Shuang Geng, Chenchen Chen, Sulian Yang, Linnan Chen, Changjie Yang, Qingling Wang, Wenrui ACS Omega [Image: see text] MicroRNAs (miRNAs) play an essential role in cancer therapy, but the disadvantages of its poor inherent stability, rapid clearance, and low delivery efficiency affect the therapeutic efficiency. Loading miRNAs by nanoformulations can improve their bioavailability and enhance therapeutic efficiency, which is an effective miRNA delivery strategy. In this study, we synthesized layered double hydroxides (LDH), which are widely used as carriers of drugs or genes due to the characteristics of good biocompatibility, high loading capacity, and pH sensitivity. We loaded the suppressor oncogene miR-30a on LDH nanomaterials (LDH@miR-30a) and determined the mass ratio of miRNA binding to LDH by agarose gel electrophoresis. LDH@miR-30a was able to escape the lysosomal pathway and was successfully phagocytosed by breast cancer SKBR3 cells and remained detectable in the cells after 24 h of co-incubation. In vitro experiments showed that LDH@miR-30a-treated SKBR3 cells showed decreased proliferation and cell cycle arrest in the G0/G1 phase and LDH@miR-30a was able to regulate the epithelial–mesenchymal transition (EMT) process and inhibit cell migration and invasion by targeting SNAI1. Meanwhile, in vivo experiments showed that nude mice treated with LDH@miR-30a showed a significant reduction in their solid tumors and no significant impairment of vital organs was observed. In conclusion, LDH@miR-30a is an effective drug delivery system for the treatment of breast cancer. American Chemical Society 2023-05-15 /pmc/articles/PMC10233669/ /pubmed/37273596 http://dx.doi.org/10.1021/acsomega.2c07866 Text en © 2023 The Authors. Published by American Chemical Society https://creativecommons.org/licenses/by-nc-nd/4.0/Permits non-commercial access and re-use, provided that author attribution and integrity are maintained; but does not permit creation of adaptations or other derivative works (https://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Zhang, Shiwen Pang, Siyan Pei, Wenhao Zhu, Haitao Shi, Yingxiang Liu, Ziyang Mao, Lingyu Shi, Xiuru Tao, Shuang Geng, Chenchen Chen, Sulian Yang, Linnan Chen, Changjie Yang, Qingling Wang, Wenrui Layered Double Hydroxide-Loaded miR-30a for the Treatment of Breast Cancer In Vitro and In Vivo |
title | Layered Double
Hydroxide-Loaded miR-30a for the Treatment
of Breast Cancer In Vitro and In Vivo |
title_full | Layered Double
Hydroxide-Loaded miR-30a for the Treatment
of Breast Cancer In Vitro and In Vivo |
title_fullStr | Layered Double
Hydroxide-Loaded miR-30a for the Treatment
of Breast Cancer In Vitro and In Vivo |
title_full_unstemmed | Layered Double
Hydroxide-Loaded miR-30a for the Treatment
of Breast Cancer In Vitro and In Vivo |
title_short | Layered Double
Hydroxide-Loaded miR-30a for the Treatment
of Breast Cancer In Vitro and In Vivo |
title_sort | layered double
hydroxide-loaded mir-30a for the treatment
of breast cancer in vitro and in vivo |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10233669/ https://www.ncbi.nlm.nih.gov/pubmed/37273596 http://dx.doi.org/10.1021/acsomega.2c07866 |
work_keys_str_mv | AT zhangshiwen layereddoublehydroxideloadedmir30aforthetreatmentofbreastcancerinvitroandinvivo AT pangsiyan layereddoublehydroxideloadedmir30aforthetreatmentofbreastcancerinvitroandinvivo AT peiwenhao layereddoublehydroxideloadedmir30aforthetreatmentofbreastcancerinvitroandinvivo AT zhuhaitao layereddoublehydroxideloadedmir30aforthetreatmentofbreastcancerinvitroandinvivo AT shiyingxiang layereddoublehydroxideloadedmir30aforthetreatmentofbreastcancerinvitroandinvivo AT liuziyang layereddoublehydroxideloadedmir30aforthetreatmentofbreastcancerinvitroandinvivo AT maolingyu layereddoublehydroxideloadedmir30aforthetreatmentofbreastcancerinvitroandinvivo AT shixiuru layereddoublehydroxideloadedmir30aforthetreatmentofbreastcancerinvitroandinvivo AT taoshuang layereddoublehydroxideloadedmir30aforthetreatmentofbreastcancerinvitroandinvivo AT gengchenchen layereddoublehydroxideloadedmir30aforthetreatmentofbreastcancerinvitroandinvivo AT chensulian layereddoublehydroxideloadedmir30aforthetreatmentofbreastcancerinvitroandinvivo AT yanglinnan layereddoublehydroxideloadedmir30aforthetreatmentofbreastcancerinvitroandinvivo AT chenchangjie layereddoublehydroxideloadedmir30aforthetreatmentofbreastcancerinvitroandinvivo AT yangqingling layereddoublehydroxideloadedmir30aforthetreatmentofbreastcancerinvitroandinvivo AT wangwenrui layereddoublehydroxideloadedmir30aforthetreatmentofbreastcancerinvitroandinvivo |